Start-Up Quarterly Statistics, Q4 2012

Start-ups raised a total of $670.3 million across all industries in Q4 2012, just $11.6 million less than in Q3, and 90% of that money went to biopharma companies. Several start-up companies inked deals with Big Pharmas, and there were three acquisitions – two in biopharma and one in the device sector.

In the fourth quarter of 2012, start-up companies raised a total of $670.3 million across all industries, which was just $11.6 million less than in Q3. (See Exhibit 1.) Biopharmas brought in 90% of the money ($602.4 million) and medical device companies raised only $48.2 million during Q4, nearly four times less than in the previous quarter. In vitro diagnostic start-ups’ fundraising also lagged, with only $19.7 million raised.

Exhibit 1

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Deals

More from Business